J&J | JNJ - Assets

Stock Price
225.31
Daily Change
-2.19 -0.96%
Monthly
-7.08%
Yearly
45.03%
Q2 Forecast
222.63

J&J reported $200.89B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Abbott USD 86.71B 2.53B Dec/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
CONMED USD 2.33B 3.26M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.7B 425M Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intuitive Surgical USD 20.11B 347.7M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025
Zoetis USD 15.47B 308M Dec/2025